U.S., Nov. 18 -- ClinicalTrials.gov registry received information related to the study (NCT07941544) titled 'Njinsky Ambispective Cellular Product Safety and Outcomes Registry' on Nov. 05.

Brief Summary: This ambispective observational registry will describe safety events, treatment patterns, and disease-specific clinical assessments among patients receiving cultured umbilical cord mesenchymal stromal cells (UCMSCs), autologous uncultured stromal vascular fraction (SVF), or both as part of routine care at Njinsky Medical Centre. The registry includes separate cohorts for retinitis pigmentosa, autism spectrum disorder, female infertility conditions, and azoospermia. The retrospective component will use eligible routine-care records from 1 J...